China-Israel Biological Technology Co., Ltd

中以生物科技有限责任公司 简 介 China-Israel Biological Technology Co. LTD Introduction 2017年7月，中以生物与长沙市政府和长沙高新技术开发区，正式签约建立中国第一个专注于特定国家合作的国际医疗科技园区--"以色列生命科学园"，由政府进行园区的硬件投资（园区占地规模超过20万平方米），由中以生物独家进行平台的管理及运营。 中以生物目前已获得中国政府境外美元投资的全部许可，目前已启动对以色列的项目投资。并计划2017年在以色列完成超过10家医疗科技企业的投资。未来三年内，预计在以色列的总投资项目将超过100家。 In July, 2017, CIB, Changsha Municipal Government and Changsha High-Tech Zone signed an agreement of establishing "Israel Life Science Park"which is the first international medical technology park concentrated in one country. The Government will do hardware investment (the park covers an area of more than 200,000 square meters), and CIB will manage and operate the platform. CIB has already gotten the approval of overseas USD investment by Chinese Government, and initiated the investment in Israel projects. And we plan to achieve more than 10 investments in Israel medical technology companies and the estimated number of investment projects in Israel in 3 years will exceed 100. 中以生物是上市公司进行海外项目并购的专业服务平台，专注于在以色列生物医疗领域高科技项目投资、引进国内孵化和产业化发展，致力打造中国-以色列生物医疗领域的"阿里巴巴"。 China-Israel Biological Technology is a professional service platform for listed companies to conduct overseas project acquisitions. It focuses on high-tech projects investment in the biomedical field in Israel, the introduction of domestic incubation and industrialization development, and is committed to building China-Israel biomedical field's "Alibaba".

• Employees 4
• Founded 2017